Breaking
India's startup sector sees fresh AI investment wave • IPL 2026 audience numbers hit new records • New Delhi prepares for major international summit • Monsoon outlook watched closely by businesses and farmers • Sensex extends gains as foreign inflows return • Bollywood box office posts strong May numbers •India's startup sector sees fresh AI investment wave • IPL 2026 audience numbers hit new records • New Delhi prepares for major international summit • Monsoon outlook watched closely by businesses and farmers • Sensex extends gains as foreign inflows return • Bollywood box office posts strong May numbers •
Startups

Sunfox's $7 Million Round Puts Cardiac Diagnostics In The Village Clinic

The Dehradun medtech startup, founded by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola and Saurabh Badola, is scaling portable ECG access after a new Series A raise.

MN
Meera Nair
Published October 8, 2026
Sunfox's $7 Million Round Puts Cardiac Diagnostics In The Village Clinic
Sunfox Technologies' Spandan platform is built around portable ECG devices and remote cardiac review for smaller clinics and homes.

Sunfox Technologies' new Series A round is a founder story about taking cardiac diagnostics outside the hospital corridor. The Dehradun medtech startup has raised $7 million, around Rs 67 crore, in a round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital and 3one4 Capital.

The company was founded in 2016 by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola and Saurabh Badola. That origin matters because Sunfox is not pitching a wellness gadget. It is trying to make ECG capture and remote interpretation available in homes, clinics, telemedicine networks and public-health settings where cardiologists are scarce.

Its Spandan devices allow health workers or users to record ECGs through a smartphone and send them for doctor review. The accompanying Spandan One platform supports remote ECG review, case coordination and tele-ECG network management, including workflows where nurses at primary or community health centres send readings to doctors at district hubs.

Sunfox says around 60,000 Spandan devices have been deployed across India, reaching more than 20,000 villages. It also says the platform supports screening of around five million patients annually, while the company has a presence in more than 15 countries.

The fresh capital is planned for expansion of the cardiac diagnostics platform, team growth, research and development, clinical evidence, engineering and new cardiac technologies. The company has also said it will build regulatory, distribution and commercial capabilities across the US, Europe and Africa.

The harder test is evidence and trust. Portable cardiac tools can help close access gaps, but they also need reliability, clinician acceptance, training and clear escalation pathways when a reading flags risk. The product only matters if a patient in a smaller town can move from screening to care without delay.

For India's healthtech market, Sunfox is a useful signal. Investors are still backing founders who combine hardware, software and public-health distribution, but the promise will be measured in field adoption, not pitch decks. If Spandan can make early cardiac assessment ordinary in smaller clinics, this round could have impact well beyond startup funding tables.

Meera Nair reports for The Indian Daily Post on startups and policy.

Related Stories

More from Startups

The Daily Post Briefing

Start your morning with the biggest stories from across India.

Politics, business, sport, lifestyle and culture — in one quick daily email.

Free. Unsubscribe anytime.